Company Filing History:
1 out of 183 
1 out of 14 Years Active: 2017
Title: Caroline Pabst: Innovator in Acute Myeloid Leukemia Research
Introduction
Caroline Pabst is a notable inventor based in Montreal, Canada. She has made significant contributions to the field of cancer research, particularly in the study of acute myeloid leukemia (AML). Her innovative approaches aim to improve treatment outcomes for patients suffering from this challenging disease.
Latest Patents
Caroline Pabst holds a patent for her work titled "Methods to modulate acute myeloid leukemia stem/progenitor cell expansion and/or differentiation." This patent discloses novel methods for modulating AML stem/progenitor cell expansion and differentiation. The methods are based on the use of aryl hydrocarbon receptor (AhR) modulators and compounds of specific formulas. Additionally, the patent includes screening assays to identify compounds that may inhibit or eliminate AML initiating cells using AhR modulators. Furthermore, it discusses the use of pharmaceutically acceptable agonists of the AhR for preventing or inhibiting minimal residual disease (MRD) in AML patients.
Career Highlights
Throughout her career, Caroline has worked with esteemed institutions, including the Université de Montréal and Rsem, Limited Partnership. Her research has focused on developing innovative strategies to combat AML, showcasing her dedication to advancing medical science.
Collaborations
Caroline has collaborated with notable professionals in her field, including Guy Sauvageau and Josée Hébert. These partnerships have contributed to her research and the development of her patented methods.
Conclusion
Caroline Pabst is a pioneering inventor whose work in acute myeloid leukemia research has the potential to transform treatment approaches. Her innovative methods and collaborations highlight her commitment to improving patient outcomes in the fight against cancer.